摘要
报告在抗感染、吸氧、改善通气、小剂量强心及利尿剂等治疗基础上,静滴硫酸镁治疗35例慢性肺心病(CPHD)急性加重期患者,总有效率94.3%,无效率5.7%,与常规治疗的对照组总有效率74.3%、无效率25.7%相比差异显著,P值<0.05。低血钾、洋地黄中毒、心津失常的发生率也明显低于对照组,P值分别<0.001、0.01、0.05。未见副作用。故认为:镁盐佐治CPHD确有疗效,值得推广。
In addition to anti-infection, oxygen inhalation, ventilation improvement,
low dosage of digitalis and diuretics, intravenous administration of magnesium sulfate was
used in 35 chronic pulmonary heart diseases (CPHD) in their acute aggravating stage. There
are significanty differences between treatment group and control group in total clinical suc-
cess rate (94. 3% to 74. 3%)and failure rate (5. 7%to 25. 7%) (P<0. 05). The incidence of
hypopotassium,digitalism,arrhythmia was lower in treatment group than in control (P<0.
001, 0. 01, 0. 05, respectively). There were no side effects. We suggested that it is effective
for magnesium salt adjuvant to treat the patients with CPHD.
关键词
硫酸镁
肺心病
心力衰竭
呼吸衰竭
magnesium sulfate
chronic pulmonary heart disease,heart failure
respiratory failure
